MwanzoLSTA • NASDAQ
add
Lisata Therapeutics Inc
Bei iliyotangulia
$ 5.01
Bei za siku
$ 5.01 - $ 5.03
Bei za mwaka
$ 1.81 - $ 5.06
Thamani ya kampuni katika soko
45.34M USD
Wastani wa hisa zilizouzwa
elfu 72.69
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 100.00 | -90.00% |
Matumizi ya uendeshaji wa biashara | 3.18M | -46.56% |
Mapato halisi | -2.95M | 35.92% |
Kiwango cha faida halisi | elfu -2.95 | -540.78% |
Mapato kwa kila hisa | — | — |
EBITDA | -3.06M | 37.57% |
Asilimia ya kodi ya mapato | 0.00% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 15.96M | -48.93% |
Jumla ya mali | 17.74M | -49.31% |
Jumla ya dhima | 3.14M | -44.71% |
Jumla ya hisa | 14.60M | — |
hisa zilizosalia | 9.03M | — |
Uwiano wa bei na thamani | 2.98 | — |
Faida inayotokana na mali | -38.97% | — |
Faida inayotokana mtaji | -48.53% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -2.95M | 35.92% |
Pesa kutokana na shughuli | -3.25M | 28.25% |
Pesa kutokana na uwekezaji | 0.00 | -100.00% |
Pesa kutokana na ufadhili | elfu 205.00 | 313.54% |
Mabadiliko halisi ya pesa taslimu | -3.04M | 7.82% |
Mtiririko huru wa pesa | -2.35M | 20.28% |
Kuhusu
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
Ilianzishwa
1980
Makao Makuu
Tovuti
Wafanyakazi
21
